These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Elimination of Radiation-Induced Senescence in the Brain Tumor Microenvironment Attenuates Glioblastoma Recurrence. Fletcher-Sananikone E; Kanji S; Tomimatsu N; Di Cristofaro LFM; Kollipara RK; Saha D; Floyd JR; Sung P; Hromas R; Burns TC; Kittler R; Habib AA; Mukherjee B; Burma S Cancer Res; 2021 Dec; 81(23):5935-5947. PubMed ID: 34580063 [TBL] [Abstract][Full Text] [Related]
4. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy. Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199 [TBL] [Abstract][Full Text] [Related]
5. Radiotherapy-Induced Astrocyte Senescence Promotes an Immunosuppressive Microenvironment in Glioblastoma to Facilitate Tumor Regrowth. Ji J; Ding K; Cheng B; Zhang X; Luo T; Huang B; Yu H; Chen Y; Xu X; Lin H; Zhou J; Wang T; Jin M; Liu A; Yan D; Liu F; Wang C; Chen J; Yan F; Wang L; Zhang J; Yan S; Wang J; Li X; Chen G Adv Sci (Weinh); 2024 Apr; 11(15):e2304609. PubMed ID: 38342629 [TBL] [Abstract][Full Text] [Related]
6. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies. D'Ambrosio M; Gil J Dev Cell; 2023 Jun; 58(12):1007-1021. PubMed ID: 37339603 [TBL] [Abstract][Full Text] [Related]
7. A guide to senolytic intervention in neurodegenerative disease. Lee S; Wang EY; Steinberg AB; Walton CC; Chinta SJ; Andersen JK Mech Ageing Dev; 2021 Dec; 200():111585. PubMed ID: 34627838 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic opportunities for senolysis in cardiovascular disease. Sweeney M; Cook SA; Gil J FEBS J; 2023 Mar; 290(5):1235-1255. PubMed ID: 35015342 [TBL] [Abstract][Full Text] [Related]
9. Abrogation of Cellular Senescence Induced by Temozolomide in Glioblastoma Cells: Search for Senolytics. Beltzig L; Christmann M; Kaina B Cells; 2022 Aug; 11(16):. PubMed ID: 36010664 [TBL] [Abstract][Full Text] [Related]
10. Cell senescence in neuropathology: A focus on neurodegeneration and tumours. Carreno G; Guiho R; Martinez-Barbera JP Neuropathol Appl Neurobiol; 2021 Apr; 47(3):359-378. PubMed ID: 33378554 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological Targeting of Senescence with Senolytics as a New Therapeutic Strategy for Neurodegeneration. Richardson M; Richardson DR Mol Pharmacol; 2024 Jan; 105(2):64-74. PubMed ID: 38164616 [TBL] [Abstract][Full Text] [Related]
12. Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy. Carpenter V; Saleh T; Min Lee S; Murray G; Reed J; Souers A; Faber AC; Harada H; Gewirtz DA Biochem Pharmacol; 2021 Nov; 193():114765. PubMed ID: 34536356 [TBL] [Abstract][Full Text] [Related]
13. EA.hy926 Cells and HUVECs Share Similar Senescence Phenotypes but Respond Differently to the Senolytic Drug ABT-263. Abdelgawad IY; Agostinucci K; Ismail SG; Grant MKO; Zordoky BN Cells; 2022 Jun; 11(13):. PubMed ID: 35805077 [TBL] [Abstract][Full Text] [Related]
14. The role of cellular senescence and SASP in tumour microenvironment. Takasugi M; Yoshida Y; Hara E; Ohtani N FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956 [TBL] [Abstract][Full Text] [Related]